与老年人抗高血压药物的坚持相关的因素
Jack Roberto Silva Fhon1, María Del Pilar Gómez-Luján2, Gideany Maiara Caetano3
1University of São Paulo, São Paulo, Brazil. E-mail: betofhon@usp.br Universidade de São Paulo University of São Paulo São Paulo Brazil betofhon@usp.br.
Revista Cuidarte
|March 21, 2025
概括
大多数老年人不坚持高血压治疗. 诸如年龄,退休和中风史等因素会影响遵守. 教育是改善老年人药物管理的关键.
科学领域:
- 老年学是一门学科.
- 心血管健康 心血管健康
- 公共卫生 公共卫生
背景情况:
- 老龄化增加了包括高血压在内的慢性疾病风险.
- 有效的高血压管理对于预防老年人的严重健康问题至关重要.
- 药物坚持是成功治疗高血压的关键组成部分.
研究的目的:
- 在社区居住的老年人中确定与坚持高血压治疗相关的因素.
- 调查社会人口统计学和健康因素与老年人群治疗坚持之间的关系.
主要方法:
- 在秘鲁进行了一项量化,横截面的研究,对342名老年人进行了调查.
- 通过社会人口统计形式,人体测量和血压测量,MMSE,GDS和Morisky Green Levine (MGL) 坚持度表收集的数据.
- 使用了描述性和推断性的统计分析.
主要成果:
- 超过一半 (57.60%) 的参与者表现出对药物治疗高血压的不坚持.
- 在大多数社会人口统计学变量中,不遵守是普遍存在的.
- 在治疗坚持和年龄 (p=0.01),退休状态 (p=0.05) 和中风病史 (p=0.004) 之间发现了显著的关联.
结论:
- 老年人对治疗的坚持受到社会人口统计学和健康相关因素的复杂相互作用的影响.
- 对老年人和护理人员来说,有针对性的干预和教育是必要的,以改善药物坚持.
- 提高坚持是有效的高血压管理和老年人的整体健康结果至关重要的.
相关概念视频
Factors affecting Blood pressure
2.9K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
2.9K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
34
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
34
Factors Affecting Drug Distribution: Miscellaneous Factors
212
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
212
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
436
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
436


